Risk-sharing agreements 

Risk-sharing models are becoming more common in the case of hospital-only medicines, while decisions on conditional reimbursement are stabilizing in the price and reimbursement processes of retail medicines. By means of risk-sharing agreements, the uncertainty about the cost and effectiveness of medicines can be divided and managed in a way that satisfies both parties. This will ultimately enable the drug to be used by patients in need.

By combining the wide-ranging expertise of Medaffcon and the management systems for risk-sharing models constructed by Tamro and hospital pharmacies (Tamro LINK), we can provide a comprehensive solution for the implementation of your risk-sharing models.


Our service concept includes that we:

  • design an optimal risk-sharing model from the perspective of both parties.
  • evaluate the cost-effectiveness of the selected model and the budget impact for both parties.
  • are responsible for the agreement negotiations with hospitals, providing a neutral expert view on what sort of a model could be acceptable for both parties.
  • organise the transfer of money and goods on a “turn-key” principle, regardless of whose distribution service is used (Tamro, Oriola, Magnum)


A successful risk-sharing agreement

  • helps the parties to work in a closer cooperation in the implementation and evaluation of a new form of treatment.
  • helps all parties evaluate and set the value for a new or existing form of treatment in a more precise manner.
  • decreases the risk of paying “too much”, for example in cases where the effectiveness of new forms of treatment is still a bit unsure – and it enables the faster implementation and use of such treatment with a more sustainable pricing model.
  • enables faster and more extensive market access of a new form of treatment.

We are more than happy to tell you more!

Contact us

Our Risk-Sharing Agreements Experts:

Jarmo Hahl
Managing Director

Jarmo Hahl

Managing Director
M.Sc. (Economics)

+358 40 139 4001 LinkedIn

Jarmo joined Medaffcon as a Partner and Managing Director in 2010, after previously working in different positions in the pharmaceutical industry for eight years. Jarmo holds a comprehensive understanding of the pharmaceutical field: he has worked in several expert and leading positions, e.g. as a Health Economic Expert, Head of a Pricing and Reimbursement Unit and as a Director of Health Economics and Market Access teams. Before moving to the pharmaceutical industry, Jarmo had a permanent position in Turku School of Economics and he worked as a researcher at Turku University Hospital.

Due to his background, Jarmo has a strong knowledge of how new health technological innovations can meet the requirements and expectations of authorities, markets and customers. Medaffcon also benefits from his comprehensive experience in Health Economics and its applications from the perspective of research and commercialisation. In addition, he has wide-ranging understanding of the constantly changing operational environment.

Jarmo deems Market Access as multidisciplinary and crucial to business, which makes it an extremely interesting field of operation.

Kalle Snicker
Sr. Market Access Specialist

Kalle Snicker

Sr. Market Access Specialist

+358 400 526597 LinkedIn

Kalle Snicker joined Medaffcon’s team in September 2017. Kalle has worked a total of 26 years in the pharmaceutical industry; 16 years in cardiovascular and 10 years in oncology therapeutic areas. Along the years, he has gained experience in leading positions in sales and marketing, in running the Baltic business unit, and in recent years, in leading the oncology market access functions at Novartis.

Kalle’s principle has always been to work for the benefit of the patient, regardless of the position he is working in. Kalle’s strengths include his extensive and comprehensive view on how the industry functions as well as his ability to predict how future challenges can be considered and how the best possible result for the patient can be achieved in a new operational environment. Kalle is true a solver of difficult situations.